EUVIMEDObjevte EUVIMED
EditorialKommentar

Editorial: terlipressin in patients with acute‐on‐chronic liver failure grade 3—too late?

Jonel Trebicka iD, Alexander Zarbock

Alimentary Pharmacology & Therapeutics · 2023

DOI: 10.1111/apt.17244 ↗

At a glance

Editorial in Alimentary Pharmacology & Therapeutics, 2023. Written by Jonel Trebicka and 1 co-authors. Institution: Department of Internal Medicine B, University of Münster, Münster, Germany. Major MEDLINE topics: Acute-On-Chronic Liver Failure. Cited 3 times so far (Crossref); 7 references. Funded by: Deutsche Forschungsgemeinschaft.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

LINKED CONTENT This article is linked to Wong et al papers. To view these articles, visit https://doi.org/10.1111/apt.17195 and https://doi.org/10.1111/apt.17323

Subjects

MeSH terms (MEDLINE)

Acute-On-Chronic Liver FailureHumansTerlipressin

Substances

Terlipressin

Authors and institutions

  • Department of Internal Medicine B, University of Münster, Münster, Germany.
  • European Foundation for the Study of Chronic Liver Failure, Barcelona, Spain.
  • Department of Anesthesiology, Intensive Care and Pain Medicine, University of Münster, Münster, Germany.

ORCID profiles: Jonel Trebicka

Funding

  • Deutsche Forschungsgemeinschaft

Cite

APA

Trebicka, J., & Zarbock, A. (2023). Editorial: terlipressin in patients with acute‐on‐chronic liver failure grade 3—too late?. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.17244

Vancouver

Trebicka J, Zarbock A. Editorial: terlipressin in patients with acute‐on‐chronic liver failure grade 3—too late?. Alimentary Pharmacology & Therapeutics. 2023. doi:10.1111/apt.17244

BibTeX
@article{Trebicka2023,
  author = {Trebicka, Jonel and Zarbock, Alexander},
  title = {Editorial: terlipressin in patients with acute‐on‐chronic liver failure grade 3—too late?},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2023},
  doi = {10.1111/apt.17244}
}
Start for free →